Tetralogic Pharma (TLOG) Stock Price & Analysis
TLOG Stock Chart & Stats
- Day’s Range
- $0.01 - $0.01
- 52-Week Range
- $0.01 - $0.01
- Previous Close
- $0.01
- Volume
- 500
- Average Volume (3M)
- 2,286
- Market Cap
- $24
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- $5.89M
- Total Debt (Recent Filing)
- $30.81M
- Price to Earnings (P/E)
- 0.0
- Beta
- 166.26
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
TLOG FAQ
What was Tetralogic Pharma’s price range in the past 12 months?
What is Tetralogic Pharma’s market cap?
When is Tetralogic Pharma’s upcoming earnings report date?
Is Tetralogic Pharma overvalued?
Does Tetralogic Pharma pay dividends?
What is Tetralogic Pharma’s EPS estimate?
How many shares outstanding does Tetralogic Pharma have?
Which hedge fund is a major shareholder of Tetralogic Pharma?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Tetralogic Pharma
TetraLogic Pharmaceuticals Corporation operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on identifying and advancing small-molecule treatments for cancer and infectious diseases. The company's development pipeline features two key clinical-stage drug candidates: birinapant and SHAPE. Birinapant, a small molecule, functions as a Second Mitochondrial Activator of Caspases (SMAC) mimetic, promoting programmed cell death, or apoptosis, in compromised cells. SHAPE, another proprietary compound, is a histone deacetylase (HDAC) inhibitor intended for topical administration to address early-stage cutaneous T-cell lymphoma. Furthermore, TetraLogic Pharmaceuticals has a research collaboration with the Walter and Eliza Hall Institute of Medical Research to explore the application of SMAC-mimetics, including birinapant, in treating infectious diseases. Founded in 2001 as Gentara Corporation, the company adopted its current name, TetraLogic Pharmaceuticals Corporation, in January 2006 and maintains its headquarters in Malvern, Pennsylvania.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yigong Shi
- Employees
- 29
- Website
- www.tetralogicpharma.com
- Address
- 343 Phoenixville Pike, Malvern, PA, 19355, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 2 | 2 | 2 |
| Technical Analysis | 0 | 0 | 0 |
| Moving Averages | 2 | 2 | 2 |